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PURPOSE: To mvestigate traditional and novel risk factors
(homocysteme and C-reactive protem levels, and exposure to
mfections) for penpheral artenal disease m young women.
SUBJECTS AND METHODS: In a multicenter, population-
based, case-control study, 212 young women (mean [± SD]
age, 48.2 ± 7.0 years) with penpheral artenal disease and 475
healthycontrolwomen(meanage,45.5 ±8.1 years) completed
a standardized questionnaire and provided blood samples Pe-
ripheral artenal disease was angiographically confirmed if a ste-
notic lesion (more than 50% reduction of the lumen) was
present m at least one major perrpherai artery. Hyperhomocys-
tememia was defined äs a nonfastmg plasma homocysteme level
exceedmg the 90th percentile of the control group. History of
mfectious diseases was determmed by questionnaire
RESULTS: Elevated C-reactive protem levels were associated
with an mcreased likelihood of penpheral artenal disease (odds
ratio [OR] = 3.9; 95% confidence interval [CI]: 1.8 to 8 5 for
women m the third quartile; OR = 3.1; 95% CI: 1.4 to 6.8 for
women in the fourth quartile; both comparisons with women in
the first quartile) Hyperhomocystememia was not associated
with a significantly mcreased risk of penpheral arterial disease
(OR = 1.6; 95% CI: 0.9 to 3.0). A history of chickenpox, shm-
gles, mumps, pneumonia, chronic bronchitis, peptic ulcer, or
penodontitis was mdependently related to penpheral arterial
disease, with adjusted odds ratios varymg from 1.7 (95% CI: 1.0
to 3.1) for mumps to 3.4 (95% CI: l 5 to 7.7) for peptic ulcer.
The risk of penpheral arterial disease mcreased with the number
of these mfections; exposure to five or more mfections mcreased
the odds 3.7-fold (95% CI: 1.7 to 8.2). This association was not
affected by the level of C-reactive protem.
CONCLUSION: Our results do not support a strong relation
between homocysteme and penpheral arterial disease m young
women. However, an elevated C-reactive protem level and sev-
eral types of symptomatic mfection were associated with pe-
ripheral artenal disease. Am J Med. 2002;! 13:462-467. ©2002
by Excerpta Medica, Inc.
Previous reports have indicated that only 1% to 7%of patients with peripheral arterial disease are 50years of age or younger (l) and that men are af-
fected 10 times more often than women (2). Therefore,
peripheral arterial disease is rare in young women, in
whom little is known about its etiology. Indeed, only a
few case series describe the conventional cardiovascular
risk factors in young women with peripheral arterial dis-
ease (3-5).
Recently, several novel risk factors for peripheral arte-
rial disease have been proposed, in particular, an elevated
homocysteine level, chronic infections, and infection-
related biomarkers, such äs C-reactive protein level. Ele-
vated C-reactive protein levels were a strong predictor of
the risk of peripheral arterial disease in a cohort of U.S.
male physicians (6,7). Elevated levels of total plasma ho-
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mocysteine have been linked to oxidative damage of the
vascular endothelium, proliferation of vascular smooth
muscle cells, and lipid peroxidation. These reactions may
accelerate atherogenesis, which could lead to peripheral
arterial disease (8). In a follow-up study of 572 patients
with coronary artery disease (9), infectious bürden was
related to peripheral arterial disease and carotid artery
Stenosis.
In this case-control study of young women, we studied
the relation between novel risk factors (i.e., homocysteine
and C-reactive protein levels, and previous infections)
and peripheral arterial disease.
SUBJECTS AND METHODS
Study Design
Analyses were performed within the Risk of Arterial
Thrombosis In relation to Oral contraceptives (RATIO)
study, a multicenter, population-based, case-control
study that was conducted between January 1990 and
October 1995 to investigate the relation between oral
contraceptive use and vascular diseases (stroke, myocar-
dial infarction, and peripheral arterial disease) in young
women in the Netherlands. In the first phase of the study,
a standardized questionnaire was sent to all patients and
control subjects (10). Later, all respondents were asked to
participate in the second phase of the study. The group of
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patients with peripheral arterial disease was augmented
with women referred between November 1995 and De-
cember 1999. In this phase, we asked all participants to
provide blood samples and to complete a standardized
questionnaire about previous infections. The patients
who had not been included in the first phase of the study
also received a questionnaire about cardiovascular risk
factors and oral contraceptive use. The study protocols
were approved by the ethics committees of all the partic-
ipating hospitals, and informed consent was given by all
participants.
Patients with Penpheral Arterial Disease
Women were eligible if they had been referred to one of
the collaborating hospitals between January l, 1990, and
December 31, 1999, with typical Symptoms of intermit-
tent claudication (cramping pain in the lower leg [s] dur-
ing exercise) or with rest pain, nonhealing ulcers, or gan-
grene; were aged 18 to 49 years at the time of referral; had
an angiographically confirmed diagnosis of peripheral ar-
terial disease; and had given informed consent. Periph-
eral arterial disease was angiographically confirmed when
a stenotic lesion causing more than 50% reduction of the
lumen was present in at least one major peripheral artery
(distal abdominal aorta, common iliac artery, internal
and external iliac artery, femoral artery, popliteal artery,
anterior and posterior tibial artery, or peroneal artery).
Of the 294 eligible patients, 24 (8%) could not be lo-
cated. Of the 270 remaining patients, 212 (79%) agreed to
complete the questionnaire about infections and to pro-
vide blood samples, including 113 (53%) who had also
participated in the first phase of the study.
Control Subjects
In the first phase of the study, 925 population-based con-
trol women about the same age (5-year strata) äs the pa-
tients were recruited by random digit dialing (10). In the
second phase, 475 of these women completed the ques-
tionnaire about infections and provided blood samples.
The most common reasons for refusal to participate in
the second phase of the study were lack of time and fear of
venipuncture.
Risk Factor Assessment
All patients and control women completed the same stan-
dardized questionnaire that asked about medication use
and cardiovascular risk factors (smoking, body mass in-
dex, oral contraceptive use, history of hypertension, his-
tory of diabetes melhtus, and history of hypercholester-
olemia). Blood pressure was measured semiautomatically
(OmronM; OMRON Healthcare GmbH, Hamburg,
Germany). Serum and plasma were stored at — 80°C untü
processed. Serum total and high-density lipoprotein cho-
lesterol, triglyceride, and glucose levels were measured
with a clinical analyzer (Röche/Hitachi 747, Mannheim,




Charactenstic (n = 212) (n = 475)
Number (%) or Mean ± SD
Age (years)
































































4.0 ± l 3
132 ±81
*Use of hpid-lowermg medication or cholesterol level &193 mg/dL.
fUse of a blood-glucose-lowermg medication or (nonfastmg) glucose
level > 198 mg/dL
*Use of anühypertensive drugs, systohc blood pressure s 160 mm Hg,
or diastolic blood pressure s 95 mm Hg
5To convert total cholesterol, LDL cholesterol, and HDL cholesterol
from mg/dL to mmol/L, multiply by 0.0259 To convert tnglycendes
from mg/dL to mmol/L, multiply by 0 0113 To convert glucose from
mg/dL to mmol/L, multiply by 0 05551.
HDL = high-density lipoprotein, LDL = low-density lipoprotein
Germany). Low-density lipoprotein cholesterol levels
were calculated with the Friedewald equation.
Information about a history of infectious diseases (in-
fectious mononucleosis, chickenpox, shingles, fever blis-
ter, mumps, hepatitis A or B, pneumonia, bronchitis,
peptic ulcer, periodontitis, and gingivitis) was obtained
by questionnaire. Total plasma homocysteme levels were
measured by high-pressure liquid chromatography (11),
and includes the sum of free and bound forms of homo-
cysteine, homocystine, and homocysteine-cysteme
mixed disulfide. Plasma C-reactive protein level was mea-
sured using an enzyme immunoassay (C-reactive protein
EAI HS; Kordia, Leusden, The Netherlands). All mea-
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Odds Ratio (95% Confidence Interval)
0 7 (0 3-1 6)
1 2 (0 6-2 3)
2 1 (1 3-3 5)
1 3 (0 9-1 8)
15(10-24)
1 5 (0 5^1 3)
3 4 (0 6-20)
2 1 (1 4-3 1)
1 8 (1 2-2 5)
4 6 (2 4-8 9)
3 4 (2 0-5 9)
15(10-25)
1 1 (0 5-2 8)
1 9 (0 9-3 9)
2 1 (1 2-38)
1 1 (0 7-1 6)
1 5 (0 9-2 4)
1 6 (0 5-5 0)
2 2 (0 3-14)
1 9(1 2-30)
1 7 (1 2-2 6)
3 0 ( 1 5-6 3)
3 6 (2 0-6 7)
18(10-30)
1 7 (0 6-4 4)
3 1 (1 3-7 7)
2 6 ( 1 3-5 1)
1 1 (0 7-1 7)
1 7 (1 0-3 1)
1 5 (0 4-6 2)
3 0 (0 3-29)
1 9 (1 2-3 3)
1 8 (1 1-3 0)
3 4 ( 1 5-7 7)
30(14-63)
1 2 (0 6-2 2)
* Adjusted for age, body mass index Smoking hypercholesterolemia, diabetes melhtus, hypertension educaüon, oral contraceptive use, and C reac
tive protem and homocysteme levels
tWomen who answered ' yes' or no were mcluded m the analyses
'Only women without dentures were asked about penodonütis and gmgivitis
surements were performed without knowledge of case or
control Status
Definition ofRisk Factors
A history of infection was defined äs a "yes" answer to the
question concerned The answers "no" and "I don't
know" were classified äs "not exposed to infection" for all
mfections except chickenpox and mumps Women who
had answered "I don't know" on these two variables
were excluded from the analyses Hyperhomocysteme-
mia was defined äs a nonfastmg plasma total homocys-
teme level exceeding the 90th percentile of the control
group (S2 16 mg/L)
Women who smoked were categonzed äs current,
former, or never Body mass mdex was calculated äs
kg/m2 Education was defined äs the highest level of
education attamed pnmary school, secondary school, or
higher education/university Current oral contraceptive
use was defined äs use withm l month before the date of
completion of the questionnaire A history of diabetes
mellitus was defined by the use of glucose-lowermg
medication or a (nonfastmg) serum glucose level
s 198 mg/dL A history of hypercholesterolemia was de-
fined by the use of cholesterol-lowermg medication or a
serum total cholesterol level S193 mg/dL A history of
hypertension was defined by use of antihypertensive
drugs, a systohc blood pressure ^160 mm Hg, or a dia-
stolic blood pressure ^95 mm Hg
Statistical Analysis
The crude and the adjusted odds ratlos (OR) and 95%
confidence intervals (CI), äs estimates for the relative nsk
of penpheral arterial disease, were calculated The cumu-
lative number of mfections was categonzed mto three
subgroups low (zero to one infection, reference group),
intermediate (two to four infections), and high (five or
more infections) The relation between C-reactive pro-
tein and homocysteme levels and penpheral arterial dis-
ease was assessed by calculating the nsk by quartiles
Odds ratios were first adjusted for age, smoking (cur-
rent, former, never), and education (low, middle, high)
They were then adjusted for cardiovascular nsk factors,
mcludmg age, smoking (current, former, never), body
mass index, history of hypertension (yes, no), hypercho-
lesterolemia (yes, no), diabetes mellitus (yes, no), educa-
tion (low, middle, high), current oral contraceptive use
(yes, no), C-reactive protein and homocysteme levels,
and infectious bürden (low, intermediate, high)
To evaluate whether infectious bürden and C-reactive
protem levels contnbute jointly to the nsk of penpheral
arterial disease, an analysis was performed in subjects
with a C-reactive protein level above and below the me-
dian value of the control group A multiplicative interac-
tion term was added to the logistic model to test for a
statistically significant mteraction
RESULTS
All traditional risk factors for atherosclerosis were more
common m patients with penpheral arterial disease than
m control subjects (Table 1) Patients reported a history
of more of the common infections than did the control
subjects, with the exception of infectious mononucleosis
(Table 2) The unadjusted odds ratios in women who had
been exposed to shingles, mumps, pneumoma, chromc
bronchitis, peptic ulcer, penodontitis, or gmgivitis were
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Table 3. Associations among C-Reactive Protein Level, Homocysteme Level, and the Cumulative Number of Common Infections
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* Adjusted for age, body mass mdex, smoking, hypercholesterolemia, diabetes mellitus, hypertension, education, oral contraceptive use, C-reactive
protem and homocysteme levels, and cumulative number of mfections
tQuartiles based on levels m the control group.
*Defined äs plasma total homocysteme levels exceedmg the 90th percentile of the control ränge (S2 16 mg/L) To convert homocysteme from mg/L
to μηιοΙ/L, multiply by 7 397.
§Includes mfecüous mononucleosis, chickenpox, shingles, fever blister, mumps, hepatiüs A and B, pneumoma, chromc bronchitis, peptic ulcer,
penodontitis, and gmgiviüs
statistically significant and varied between 1.5 (95% CI:
l .0 to 2.4) for mumps to 4.6 (95% CI: 2.4 to 8.9) for peptic
ulcer. Adjustment for age, smoking, and education did
not significantly affect these odds ratios; the risk associ-
ated with peptic ulcer decreased the most, to 3.0 (95% CI:
l .5 to 6.3). Adjustment for other risk factors did not cause
substantial changes in these odds ratios, except perhaps
for gingivitis (Table 2).
The risk of peripheral arterial disease in women with a
C-reactive protein level in the highest two quartiles was
increased substantially in both unadjusted and adjusted
models (Table 3). In contrast, elevated homocysteine lev-
els were not associated with peripheral arterial disease
(Table 3). Hyperhomocysteinemia was associated with an
increased risk of peripheral arterial disease, but not after
adjustment for cardiovascular risk factors (Table 3).
The risk of peripheral arterial disease increased with
the cumulative number of infections (Table 3). Level of
C-reactive protein did not affect this relation (Table 4).
DISCUSSION
We evaluated novel risk factors (C-reactive protein and
homocysteine levels, and symptomatic infections) for pe-
ripheral arterial disease in this case-control study of
young women. A C-reactive protein level in the highest
two quartiles increased the risk of peripheral arterial dis-
ease more than threefold, independently of all other risk
factors. In contrast, homocysteine level was not indepen-
dently related to peripheral arterial disease. Symptomatic
infections (chickenpox, shingles, mumps, pneumonia,
chromc bronchitis, peptic ulcer, and periodontitis) and
the infectious bürden were independent risk factors for
peripheral arterial disease.
Most previous case-control studies have reported an
association between homocysteine level and cardiovascu-
lar risk (12). A meta-analysis including more than 4000
patients reported an increased risk of coronary artery dis-
ease (OR = 1.7; 95% CI: 1.5 to 1.9), cerebrovascular dis-
ease (OR = 2.5; 95% CI: 2.0 to 3.0), and peripheral arte-
rial disease (OR = 6.8; 95% CI: 2.9 to 15.8) in patients
with increased levels of homocysteine (13). However, not
all studies have reported unequivocal evidence that ho-
mocysteme is associated with vascular disease (7,14). For
instance, a nested case-control analysis within a cohort of
14,916 initially healthy U.S. male physicians showed no
significant relation between homocysteine and periph-
eral arterial disease (7). It has been suggested that the
case-control studies may have made insufficient adjust-
ments for confounding factors, and that a high homocys-
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*Dmded mto above or below the median value (l 3 mg/L) m the control group
flncludes mfectious mononucleosis, chickenpox, shmgles, fever blister, mumps, Hepatitis A and B, pneumoma, chromc bronchiüs, peptic ulcer,
penodonütis, and gmgivitis.
* Adjusted for age, smoking, body mass index, hypercholesterolemia, diabetes mellitus, hypertension, oral contraceptive use, and homocysteme level
There was no evidence of an mteraction between Oreactive protein levels, number of mfections, and penpheral artenal disease (P > 0 10).
teine level may be a consequence rather than a cause of
vascular disease.
Few studies have analyzed the relation between clmical
Symptoms äs indicators of infection and vascular disease.
In one cohort study, Symptoms of chronic respiratory
infections predicted the risk of coronary events indepen-
dently of known cardiovascular risk factors (15). In con-
trast, two prospective studies reported no relation be-
tween self-reported periodontal disease and coronary ar-
tery disease (16,17). However, other studies that involved
dental examination have found an increased risk of cor-
onary artery disease in people with periodontal disease
(18-21).
Epidemiological studies on the relation between infec-
tion and atherosclerosis have mainly used antibody titers
against microorganisms to assess exposure Status, instead
of a history of clinical Symptoms (22,23). The advantage
of the latter approach is that clinical Symptoms may be
associated with the extent of the infiammatory reaction
caused by the infection (24). Because infections are
thought to influence atherogenesis by causing an infiam-
matory response, infections that cause mild or no clinical
Symptoms might not be related to atherogenesis.
We found that the number of self-reported infections
was related to the risk of penpheral arterial disease in
young women. Perhaps each infection evokes an infiam-
matory response that triggers the same common pathway
of cellular reactions that eventually affect the vascular en-
dothelium. Other studies have shown that greater patho-
gen bürden is related to the risk of coronary artery disease
(9,25,26). In one study, for example, people exposed to at
least one chronic infection had a fourfold risk of develop-
ing subclinical atherosclerosis in the next 5 years (25).
We found a significant and independent relation be-
tween elevated C-reactive protein levels and penpheral
arterial disease, consistent with results in men (6,7). The
mechanisms responsible for this association are uncer-
tain, but C-reactive protein induces the expression of
adhesion molecules in human endothelial cells (7,26).
Liuzzo et al. suggested that increased levels of C-reactive
protein are a marker of hyperresponsiveness of the in-
fiammatory System (27).
A potential limitation of our study is that we measured
nonfasting levels of homocysteine. Other studies, how-
ever, have shown that the plasma total homocysteine level
is influenced only modestly by food intake (breakfast)
(28). Other potential sources of bias are recall bias and
self-report of information about risk factors and infec-
tions. Adjustment for potential confounders was done in
two Steps. First, odds ratios were adjusted for age, smok-
ing, and education, and then for other vascular risk fac-
tors. This allowed us to evaluate the effects of different
adjustments. Another approach would have been to ad-
just for only those confounders that are related to periph-
eral arterial disease and the factor of interest. Potential
confounding variables such äs age, body mass index, and
C-reactive protein and homocysteine levels were entered
in the multivariate models äs continuous variables,
whereas smoking, socioeconomic Status, oral contracep-
tive use, and diabetes, hypertension, and hypercholester-
olemia were entered äs categorical variables. We chose to
adjust for diabetes, hypertension, and hypercholesterol-
emia, instead of the glucose or cholesterol level or the
actual blood pressure, because many women were being
treated for these risk factors.
In conclusion, the results of our study do not support a
strong relation between homocysteine levels and periph-
eral arterial disease in young women in The Netherlands.
However, elevated C-reactive protein levels were associ-
ated with peripheral arterial disease, äs was infectious
bürden.
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